Home Data Calendar Blog

OGN

Tables

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Weighted Average Number Of Diluted Shares Outstanding 258.60258.36NA256.35255.95256.17NA255.07255.16255.05NA254.17253.83253.52NA253.52253.52253.52
Weighted Average Number Of Shares Outstanding Basic 257.29255.69NA255.59255.34254.39NA254.35254.02253.58NA253.53253.52253.52NA253.52253.52253.52
Earnings Per Share Basic 0.760.782.140.230.950.700.420.890.921.370.801.271.681.581.452.162.142.78
Earnings Per Share Diluted 0.750.782.130.230.950.690.420.890.921.360.791.271.681.581.452.162.142.78

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenues 1607.001622.001598.001519.001608.001538.001485.001537.001585.001567.001603.001600.001595.001506.001613.001613.001526.001780.00
Cost Of Goods And Services Sold 668.00665.00683.00612.00640.00580.00594.00551.00588.00561.00599.00609.00583.00591.00586.00535.00460.00538.00
Gross Profit 939.00NANANA968.00NANANANANANANANANANANANANA
Research And Development Expense Excluding Acquired In Process Cost 116.00112.00134.00137.00128.00129.00142.00127.00106.0096.00110.0086.0076.00NANANANANA
Selling General And Administrative Expense 437.00431.00469.00538.00451.00435.00470.00440.00423.00371.00482.00388.00416.00382.00434.00321.00284.00317.00
Interest Expense 131.00131.00129.00134.00132.00132.00119.00108.0098.0097.0098.0098.0062.00NANANANANA
Allocated Share Based Compensation Expense 28.0026.0027.0027.0025.0022.0023.0018.0019.0015.0015.0015.0018.0011.008.0011.0011.0010.00
Income Loss From Continuing Operations NANA546.0058.00242.00177.00108.00227.00234.00348.00202.00323.00431.00395.00376.00560.00586.00734.00
Income Tax Expense Benefit 40.0035.00-442.0022.0012.0058.003.0055.0053.0094.0034.0066.006.0072.00149.00121.00116.00110.00
Other Comprehensive Income Loss Net Of Tax -35.00-36.0035.00-43.001.0030.00122.00-97.00-60.00-16.00-20.00-26.00212.00-68.00-95.0044.0028.00-150.00
Net Income Loss 195.00201.00546.0058.00242.00177.00108.00227.00234.00348.00202.00323.00427.00399.00368.00547.00542.00703.00
Comprehensive Income Net Of Tax 160.00165.00581.0015.00243.00207.00230.00130.00174.00332.00182.00297.00639.00331.00273.00591.00570.00553.00

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Assets 12154.0011891.0012058.0011012.0010979.0010763.0010955.0010437.0010614.0010597.0010681.0011335.0010908.009642.0010109.00NANANA
Liabilities 12010.0011843.0012128.0011601.0011534.00NA11847.00NANANANANANANANANANANA
Liabilities And Stockholders Equity 12154.0011891.0012058.0011012.0010979.0010763.0010955.0010437.0010614.0010597.0010681.0011335.0010908.009642.0010109.00NANANA
Stockholders Equity 144.0048.00-70.00-589.00-555.00-737.00-892.00-1066.00-1137.00-1250.00-1508.00-1618.00-1934.004722.005486.007335.007005.007029.00

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Assets Current 4509.004196.004508.004050.003958.003780.003931.003592.003774.003719.003760.004329.003911.002977.003567.00NANANA
Cash And Cash Equivalents At Carrying Value 704.00575.00693.00414.00326.00459.00706.00499.00545.00694.00737.001008.00730.00141.0012.00NANANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 704.00575.00693.00414.00326.00459.00706.00499.00545.00694.00737.001008.00730.00141.0012.00NANANA
Accounts Receivable Net Current 1617.001547.001744.001648.001672.001445.001475.001440.001490.001322.001382.001498.001507.001010.001038.00NANANA
Inventory Net 1287.001263.001315.001186.001199.001121.001003.00879.00950.00946.00915.00918.00871.00924.00913.00NANANA
Inventory Finished Goods 646.00435.00566.00496.00494.00479.00482.00403.00377.00373.00377.00359.00327.00399.00351.00NANANA
Inventory L I F O Reserve 5.003.00NA6.0012.0016.0020.0018.0018.0015.0011.006.002.001.001.00NANANA
Other Assets Current 901.00811.00756.00802.00761.00755.00747.00774.00789.00757.00726.00905.00803.00782.00930.00NANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NANA1017.00NANANA902.00NANANA882.00877.00873.00817.00820.00NANANA
Property Plant And Equipment Net 1162.001180.001183.001096.001110.001055.001018.00906.00952.00970.00973.00967.00976.00986.00984.00NANANA
Finite Lived Intangible Assets Net 684.00718.00533.00561.00592.00621.00649.00670.00638.00665.00651.00683.00711.00482.00503.00NANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Liabilities Current 2755.002545.002918.002491.002387.002346.002512.002328.002396.002306.002597.003129.002975.002875.002673.00NANANA
Long Term Debt Current 9.009.009.008.008.008.008.008.009.009.009.0039.0039.00NANANANANA
Accounts Payable Current 1243.00955.001314.001067.001115.00996.001132.001028.001130.001081.001382.001673.001812.00264.00259.00NANANA
Accrued Income Taxes Current 201.00196.00206.00161.00163.00192.00184.00217.00211.00202.00185.00335.00218.00288.00288.00NANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Long Term Debt 8656.008714.008760.008654.008730.008711.008913.008699.008893.009094.009134.009298.009348.00NANANANANA
Long Term Debt Noncurrent 8647.008705.008751.008646.008722.008703.008905.008691.008884.009085.009125.009259.009309.00NANANANANA
Deferred Income Tax Liabilities Net 60.0044.0047.0043.0032.0030.0019.0043.0023.002.004.0059.0071.00125.00128.00NANANA
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent NANA76.00NANANA47.00NANANA72.00NANANA36.00NANANA
Other Liabilities Noncurrent 548.00549.00412.00421.00393.00421.00411.00441.00448.00454.00463.00506.00487.001847.001739.00NANANA
Operating Lease Liability Noncurrent NANA125.00NANANA150.00NANANA184.00221.00227.00NA23.00NANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Stockholders Equity 144.0048.00-70.00-589.00-555.00-737.00-892.00-1066.00-1137.00-1250.00-1508.00-1618.00-1934.004722.005486.007335.007005.007029.00
Additional Paid In Capital Common Stock 63.0049.0025.00NANANANANANANANANANANANANANANA
Retained Earnings Accumulated Deficit 690.00573.00443.00-16.00-25.00-206.00-331.00-383.00-551.00-724.00-998.00-1128.00-1473.00NANANANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -612.00-577.00-541.00-576.00-533.00-534.00-564.00-686.00-589.00-529.00-513.00-493.00-464.00-689.00-622.00NANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 14.0024.0025.0025.0013.0021.0023.0015.0011.0015.0015.0015.008.00NANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Operating Activities 332.0076.00NA261.0027.00114.00NA317.00151.00123.00NANANANANANANANA
Net Cash Provided By Used In Investing Activities -46.00-96.00NA-55.00-70.00-54.00NA-213.00-83.00-63.00NANANANANANANANA
Net Cash Provided By Used In Financing Activities -134.00-74.00NA-78.00-88.00-326.00NA-77.00-183.00-91.00NANANANANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Operating Activities 332.0076.00NA261.0027.00114.00NA317.00151.00123.00NANANANANANANANA
Net Income Loss 195.00201.00546.0058.00242.00177.00108.00227.00234.00348.00202.00323.00427.00399.00368.00547.00542.00703.00
Increase Decrease In Other Operating Capital Net -8.00-22.0037.00-21.00-13.00-19.000.0016.00-15.007.00-9.00-20.00-11.00-15.00-5.0021.0014.00-10.00
Increase Decrease In Accounts Receivable 75.00-163.0027.00-6.00230.00-39.004.00-6.00179.00-54.00-99.004.00332.0040.00-140.00147.00-176.00156.00
Increase Decrease In Inventories 58.00-19.0093.0013.0086.0038.0086.0053.0095.00-14.0048.0092.00-35.0033.00-33.00-31.0020.0010.00
Deferred Income Tax Expense Benefit 21.005.00-489.008.00-7.003.000.00-9.00-5.00-4.00-76.00-41.00-146.00-25.00-50.008.0025.00-15.00
Share Based Compensation 28.0026.0027.0027.0025.0022.0023.0018.0019.0015.0015.0015.0018.0011.008.0011.0011.0010.00

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Investing Activities -46.00-96.00NA-55.00-70.00-54.00NA-213.00-83.00-63.00NANANANANANANANA
Payments To Acquire Property Plant And Equipment 32.0046.0079.0055.0071.0046.0063.0055.0045.0033.0059.0036.0059.0038.00121.0047.00NANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Financing Activities -134.00-74.00NA-78.00-88.00-326.00NA-77.00-183.00-91.00NANANANANANANANA
Payments Of Dividends 79.0070.0073.0074.0074.0073.0073.0074.0072.0071.0071.00NANANANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenues 1607.001622.001598.001519.001608.001538.001485.001537.001585.001567.001603.001600.001595.001506.001613.001613.001526.001780.00
Samsung Bioepis Co Ltd 165.00170.00199.00143.00135.00116.00135.00129.00118.0099.00119.00139.0085.0081.00103.0099.0060.0068.00
Arcoxia 68.0075.0050.0064.0072.0071.0056.0064.0061.0060.0060.0065.0062.0056.0054.0068.0065.0070.00
Atozet 140.00132.00122.00126.00143.00128.00107.00109.00122.00119.00111.00114.00121.00112.00105.00111.00115.00122.00
Aybintio 7.008.009.0012.0012.0010.0010.0010.009.0010.0010.0010.008.008.00NANANANA
Brenzys 12.0024.0028.0013.0013.0019.0023.0024.0014.0014.0028.0014.0011.0010.0022.0023.0011.0018.00
Clarinex 35.0037.0029.0028.0039.0039.0026.0026.0035.0038.0028.0028.0030.0025.0021.0025.0033.0051.00
Cozaar Hyzaar 60.0067.0056.0068.0071.0085.0067.0070.0092.0093.00309.0015.0086.0090.00292.0032.0098.00102.00
Diprospan 37.0029.0033.0031.0012.0014.0031.0028.0031.0031.0033.0034.0032.0026.0031.0033.0024.0029.00
Dulera 47.0056.0050.0049.0048.0046.0053.0040.0047.0040.0044.0056.0052.0038.0041.0059.0039.0083.00
Emgality Ravvow 30.00NANANANANANANANANANANANANANANANANA
Follistim A Q 62.0046.0083.0054.0070.0055.0050.0060.0058.0061.0059.0061.0065.0052.0058.0050.0044.0041.00
Fosamax 35.0040.0036.0041.0044.0038.0035.0036.0040.0041.0043.0046.0049.0038.0040.0046.0052.0041.00
Ganirelix Acetate Injection 27.0029.0022.0025.0034.0030.0026.0036.00NANANANANANANANANANA
Hadlima 28.0030.0024.008.007.005.005.006.002.006.004.005.002.002.00NANANANA
Jada 14.0013.0012.0013.0011.007.008.005.00NANANANANANANANANANA
Marvelon Mercilon 41.0033.0037.0030.0029.0037.0025.0031.0031.0024.00NANANANANANANANA
Nasonex 60.0077.0065.0055.0064.0069.0056.0049.0058.0075.0062.0048.0052.0043.0058.0041.0049.0071.00
Nexplanon Implanon N X T 242.00220.00231.00220.00214.00165.00239.00229.00195.00171.00226.00175.00184.00183.00165.00189.00132.00195.00
Nuva Ring 29.0038.0035.0037.0040.0040.0040.0050.0042.0041.0044.0049.0053.0045.0052.0058.0063.0063.00
Ontruzant 48.0039.0062.0040.0033.0021.0035.0029.0035.0022.0025.0056.0022.0022.0037.0037.0019.0022.00
Other Cardiovascular 32.0038.0029.0044.0041.0041.0039.0035.0046.0039.0027.0031.0045.0024.0038.0037.0054.0033.00
Other Non Opiod Pain Bone And Dermatology 78.0072.0068.0074.0071.0063.0063.0065.0076.0069.0051.0057.0052.0041.0051.0052.0044.0049.00
Other Respiratory 13.009.0016.0025.0019.0017.0017.0021.0022.0022.0010.003.008.005.009.0011.005.0010.00
Other Sundry Established Brands 72.0094.0079.0076.0084.0080.0075.0087.0082.0083.0066.0059.0048.0054.0059.0063.0046.0069.00
Other Sundry Products 31.0029.0019.0024.0040.0039.0030.0039.0040.0037.0032.0052.0047.0069.0057.002.0024.0025.00
Other Womens Health 34.0043.0045.0039.0052.0054.0016.0063.0067.0057.0043.0053.0066.0073.0074.0084.0082.0059.00
Propecia 28.0023.0033.0022.0036.0033.0030.0030.0035.0030.0035.0034.0036.0031.0038.0032.0028.0030.00
Proscar 23.0026.0020.0025.0025.0027.0024.0027.0026.0024.0025.0027.0032.0032.0022.0060.0051.0043.00
Renflexis 69.0069.0077.0069.0070.0062.0060.0060.0059.0046.0050.0054.0043.0038.0039.0038.0030.0028.00
Rosuzet 9.0016.0018.0017.0017.0018.0016.0017.0016.0022.00-197.0087.0018.0015.00-161.0091.0031.0032.00
Singulair 93.0098.00114.0091.0080.00120.0095.0094.0092.00130.00113.00100.0092.00107.00124.0082.00100.00155.00
Vytorin 28.0028.0029.0033.0038.0029.0026.0031.0035.0038.0037.0041.0045.0041.0043.0047.0039.0053.00
Zetia 75.0084.0067.0066.0090.0083.0070.0087.00101.0099.0096.0091.0099.0092.0098.00103.00137.00145.00
Arcoxia, Non Us 68.0075.0050.0064.0072.0071.0056.0064.0061.0060.0060.0065.0062.0056.0054.0068.0065.0070.00
Atozet, Non Us 140.00132.00122.00126.00143.00128.00107.00109.00122.00119.00111.00114.00121.00112.00105.00111.00115.00122.00
Aybintio, Non Us 7.008.009.0012.0012.0010.0010.0010.009.0010.0010.0010.008.008.00NANANANA
Brenzys, Non Us 12.0024.0028.0013.0013.0019.0023.0024.0014.0014.0028.0014.0011.0010.0022.0023.0011.0018.00
Clarinex,US 1.001.001.002.001.001.001.001.001.001.001.002.002.001.002.002.002.002.00
Clarinex, Non Us 35.0036.0029.0026.0038.0039.0025.0025.0034.0037.0028.0027.0029.0023.0019.0023.0032.0050.00
Cozaar Hyzaar,US 2.003.002.003.002.002.002.002.002.008.003.003.002.003.00NANA5.007.00
Cozaar Hyzaar, Non Us 58.0065.0055.0065.0069.0083.0066.0068.0091.0086.00297.0015.0084.0087.00271.0032.0094.0095.00
Diprospan, Non Us 37.0029.0033.0031.0012.0014.0031.0028.0031.0031.0033.0034.0032.0026.0031.0033.0024.0029.00
Dulera,US 39.0043.0040.0040.0038.0038.0042.0031.0036.0031.0033.0048.0042.0031.0033.0051.0032.0072.00
Dulera, Non Us 8.0013.0010.009.0010.008.0010.009.0012.009.0011.008.0010.008.008.008.007.0011.00
Emgality Ravvow, Non Us 30.00NANANANANANANANANANANANANANANANANA
Follistim A Q,US 22.0011.0051.0022.0026.0026.0026.0027.0023.0030.0029.0029.0027.0025.0024.0020.0020.0021.00
Follistim A Q, Non Us 40.0035.0031.0032.0044.0029.0024.0033.0035.0031.0030.0032.0038.0027.0033.0031.0024.0021.00
Fosamax,US 1.001.001.001.001.00NA2.001.001.001.001.001.001.001.001.001.001.001.00
Fosamax, Non Us 34.0038.0035.0040.0044.0037.0033.0035.0039.0040.0042.0045.0048.0037.0039.0045.0052.0040.00
Ganirelix Acetate Injection,US 5.006.004.004.004.006.006.006.00NANANANANANANANANANA
Ganirelix Acetate Injection, Non Us 22.0023.0017.0021.0029.0023.0020.0030.00NANANANANANANANANANA
Hadlima,US 20.0022.0015.002.00NANANANANANANANANANANANANANA
Hadlima, Non Us 8.008.008.006.007.005.005.006.002.006.004.005.002.002.00NANANANA
Jada,US 14.0013.0013.0012.0011.007.008.005.00NANANANANANANANANANA
Marvelon Mercilon, Non Us 41.0033.0037.0030.0029.0037.0025.0031.0031.0024.00NANANANANANANANA
Nasonex, Non Us 60.0077.0065.0054.0064.0069.0056.0049.0058.0065.0060.0049.0051.0041.0055.0041.0045.0065.00
Nexplanon Implanon N X T,US 171.00153.00154.00146.00159.00114.00172.00151.00134.00116.00143.00120.00129.00141.00114.00137.0087.00149.00
Nexplanon Implanon N X T, Non Us 70.0067.0076.0074.0056.0052.0067.0078.0061.0055.0083.0055.0056.0042.0050.0052.0044.0045.00
Nuva Ring,US 10.0016.0016.0018.0017.0015.0020.0027.0022.0016.0017.0021.0026.0021.0025.0025.0035.0026.00
Nuva Ring, Non Us 19.0022.0019.0020.0023.0024.0020.0023.0020.0024.0027.0028.0028.0024.0028.0033.0028.0037.00
Ontruzant,US 10.008.0010.0011.0012.0013.0013.0015.0012.007.0014.009.007.004.002.00NANANA
Ontruzant, Non Us 38.0031.0052.0028.0021.008.0022.0014.0023.0015.0011.0047.0015.0019.0036.0037.0018.0022.00
Other Cardiovascular,US 1.00NA0.001.001.001.000.001.001.001.001.001.001.001.00NANANANA
Other Cardiovascular, Non Us 31.0037.0027.0042.0041.0040.0039.0034.0045.0038.0027.0031.0045.0024.0038.0037.0054.0033.00
Other Non Opiod Pain Bone And Dermatology,US 5.005.003.004.002.004.005.002.005.003.004.009.003.00-1.004.003.001.001.00
Other Non Opiod Pain Bone And Dermatology, Non Us 73.0068.0065.0070.0067.0059.0057.0063.0071.0066.0046.0047.0049.0042.0046.0049.0043.0048.00
Other Respiratory,US 8.007.007.0017.0013.0012.0012.0011.0011.0012.0013.0014.0013.0016.002.000.000.001.00
Other Respiratory, Non Us 4.003.008.009.006.005.004.0010.0011.0011.0011.003.008.004.007.0011.005.009.00
Other Sundry Established Brands,US 2.005.003.005.002.004.003.006.007.008.008.009.0012.0010.009.0015.006.0022.00
Other Sundry Established Brands, Non Us 69.0089.0077.0072.0081.0076.0072.0081.0074.0074.0057.0049.0035.0043.0050.0048.0041.0046.00
Other Sundry Products,US NANA0.00NA-2.00NANANANANA-1.001.00-2.00NA0.00-1.004.001.00
Other Sundry Products, Non Us 31.0029.0018.0024.0041.0039.0031.0039.0040.0037.0034.0051.0049.0069.0056.003.0020.0023.00
Other Womens Health,US 13.0015.0020.0016.0027.0026.0030.0024.0029.0027.0016.0018.0023.0040.0044.0045.0054.0022.00
Other Womens Health, Non Us 23.0028.0027.0022.0025.0028.00-14.0039.0038.0031.0028.0035.0043.0033.0030.0039.0028.0037.00
Propecia,US 2.002.002.002.002.002.002.002.002.001.004.001.002.002.003.002.002.003.00
Propecia, Non Us 27.0021.0032.0021.0035.0031.0028.0028.0033.0029.0031.0033.0034.0029.0036.0030.0026.0027.00
Proscar,US NANA0.000.00NANA0.000.00NANA0.000.00NANA1.000.00NANA
Proscar, Non Us 23.0026.0020.0025.0024.0027.0023.0026.0026.0024.0025.0027.0031.0032.0022.0059.0051.0042.00
Renflexis,US 56.0055.0062.0057.0060.0055.0051.0054.0051.0042.0045.0048.0036.0035.0035.0034.0028.0026.00
Renflexis, Non Us 13.0014.0014.0012.0011.007.0010.007.008.004.004.006.007.004.004.004.003.002.00
Rosuzet, Non Us 9.0016.0018.0017.0017.0018.0016.0017.0016.0022.00-188.0084.0018.0015.00-144.0086.0031.0032.00
Singulair,US 2.002.003.003.003.003.003.003.003.003.005.002.003.005.004.004.004.005.00
Singulair, Non Us 90.0095.00111.0088.0077.00117.0092.0092.0089.00127.00109.0098.0089.00102.00120.0078.0095.00151.00
Vytorin,US 2.001.001.002.001.002.002.001.003.002.003.003.002.003.003.003.002.003.00
Vytorin, Non Us 26.0027.0029.0031.0037.0028.0025.0030.0032.0036.0034.0038.0042.0038.0040.0044.0037.0050.00
Zetia,US 2.002.003.002.002.002.001.002.002.003.004.001.002.002.003.00-1.00-1.00-2.00
Zetia, Non Us 73.0082.0065.0065.0089.0081.0070.0085.0099.0096.0092.0090.0097.0089.0094.00103.00138.00147.00
28.0029.0027.0028.0037.0030.0023.0038.0033.0033.0035.9040.6013.50NANANANANA
216.00206.00203.00202.00234.00225.00196.00241.00244.00236.00240.00252.00236.00205.00218.00225.00211.00219.00
US 388.00371.00411.00370.00371.00326.00394.00366.00351.00329.00348.00346.00339.00351.00340.00371.00303.00393.00
Asia Pacific And Japan 260.00287.00260.00284.00261.00324.00255.00283.00291.00314.00299.00287.00309.00285.00345.00354.00419.00419.00
Europe And Canada 457.00450.00414.00392.00467.00400.00388.00363.00443.00436.00427.00410.00470.00490.00440.00426.00378.00495.00
Latin America Middle East Russia And Africa 251.00274.00278.00239.00234.00214.00230.00236.00216.00209.00246.00238.00190.00203.00208.00228.00187.00238.00
Other Countries 35.0034.0032.0032.0041.0049.0022.0048.0040.0043.0043.0067.0051.00-28.0062.009.0028.0016.00
Non Us 1219.001251.001187.001149.001237.001212.001091.001171.001234.001238.001255.001254.001257.001155.001273.001242.001224.001387.00

Plots across concepts


IncomeStatement
Other Comprehensive Income Loss Net Of Tax
Expenses
Allocated Share Based Compensation Expense
Balance Sheet
Stockholders Equity
Assets
Operating Lease Right Of Use Asset
Current Assets
Cash And Cash Equivalents At Carrying Value
NonCurrent Assets
Operating Lease Right Of Use Asset
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Long Term Debt Current
Noncurrent Liabilities
Deferred Income Tax Liabilities Net
Stockholders Equity
Accumulated Other Comprehensive Income Loss Net Of Tax
Per Share
Common Stock Dividends Per Share Declared
CashFlow
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInOperatingActivities
Share Based Compensation
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInFinancingActivities
Net Cash Provided By Used In Financing Activities
Shares
Weighted Average Number Of Shares Outstanding Basic
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Four
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Net
InventoryNet
Inventory Finished Goods
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept